Vaccine manufacturers Pfizer and BioNTech have submitted an application to the Food and Drug Administration (FDA) seeking to expand the approval of their COVID-19 shots to individuals aged between 12 and 15, citing trial data, the company announced on Thursday.
In a statement, the companies said their application to the FDA includes updated longer-term follow-up data from their Phase 3 clinical trial of the vaccine focusing on 2,228 participants ages 12 to 15 years.
